Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 1951 to 2000 of 2529

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimenTA316
Prasugrel with percutaneous coronary intervention for treating acute coronary syndromesTA317
Ipilimumab for previously untreated advanced (unresectable or metastatic) melanomaTA319
Endoscopic radiofrequency ablation for Barrett's oesophagus with low‑grade dysplasia or no dysplasiaHTG345
Endoscopic radiofrequency ablation for squamous dysplasia of the oesophagusHTG346
Powered microdebrider turbinoplasty for inferior turbinate hypertrophyHTG347
Safe staffing for nursing in adult inpatient wards in acute hospitalsSG1
Chronic urticaria: off-label doses of cetirizineESUOM31
Facial erythema of rosacea: brimonidine tartrate gelESNM43
Implantable cardioverter defibrillators and cardiac resynchronisation therapy for arrhythmias and heart failureTA314
Canagliflozin in combination therapy for treating type 2 diabetesTA315
The geko device for reducing the risk of venous thromboembolismHTG344
Radiofrequency tissue reduction for turbinate hypertrophyHTG343
Endoscopic saphenous vein harvest for coronary artery bypass graftingHTG342
AccuVein AV400 for vein visualisationMIB6
Acoustic CR Neuromodulation for adults with chronic subjective tonal tinnitusMIB5
Teriflunomide for treating relapsing–remitting multiple sclerosisTA303
Gastroelectrical stimulation for gastroparesisHTG341
Endoscopic thoracic sympathectomy for primary hyperhidrosis of the upper limbHTG339
Arthroscopic radiofrequency chondroplasty for discrete chondral defects of the kneeHTG340
Premature ejaculation: dapoxetineESNM40
Constipation in children and young peopleQS62
Pressure ulcers: prevention and managementCG179
Afatinib for treating epidermal growth factor receptor mutation-positive locally advanced or metastatic non-small-cell lung cancerTA310
Bortezomib for induction therapy in multiple myeloma before high-dose chemotherapy and autologous stem cell transplantationTA311
Antisocial behaviour and conduct disorders in children and young peopleQS59
Infection prevention and controlQS61
Sickle cell diseaseQS58
Faecal microbiota transplant for recurrent Clostridium difficile infectionHTG338
Transoral carbon dioxide laser surgery for primary treatment of oropharyngeal malignancyHTG337
Insertion of a magnetic bead band for faecal incontinenceHTG336
Contraceptive services for under 25sPH51
Needle and syringe programmesPH52
Rituximab in combination with glucocorticoids for treating anti-neutrophil cytoplasmic antibody-associated vasculitisTA308
Pouchitis: rifaximinESUOM30
Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapyTA307
Psychosis and schizophrenia in adults: prevention and managementCG178
Managing medicines in care homesSC1
Jaundice in newborn babies under 28 daysQS57
Cancer services for children and young peopleQS55
Domestic violence and abuse: multi-agency workingPH50
Total hip replacement and resurfacing arthroplasty for end-stage arthritis of the hipTA304
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusionTA305
Pixantrone monotherapy for treating multiply relapsed or refractory aggressive non-Hodgkin's B‑cell lymphomaTA306
Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinomaHTG333
Endoscopic thoracic sympathectomy for primary facial blushingHTG331
Optical coherence tomography to guide percutaneous coronary interventionHTG332
Anxiety disordersQS53
Faecal incontinence in adultsQS54
The Versajet II hydrosurgery system for surgical debridement of acute and chronic wounds and burnsMIB1

Results per page

  1. 10
  2. 25
  3. 50
  4. All